Connection

Michael Hallek to Biomarkers

Back to Details
This is a "connection" page, showing publications Michael Hallek has written about Biomarkers.
Michael Hallek
Connection Strength
0.036
Biomarkers
  1. CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia. Leukemia. 2019 05; 33(5):1161-1172.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.